SpeeDx Pty. Ltd.
Suite G16, National Innovation Centre, Australian
4 Cornwallis Street
Eveleigh
Sydney
NSW 2015
Tel: 61-0-2-9209-4170
Website: http://www.speedx.com.au/
Email: sales@speedx.com.au
About SpeeDx Pty. Ltd.
Based in Sydney, Australia and founded in 2009, SpeeDx is a privately owned company specializing in innovative multiplex real-time polymerase chain reaction (qPCR) solutions for clinical diagnostics. SpeeDx has a portfolio of market leading detection and priming technologies to enable new healthcare paradigms based on improved delivery and reduced costs. SpeeDx has a proven track record of scientific discovery and strives to provide cutting edge clinically relevant tools for the clinical diagnostic market.YEAR FOUNDED:
2009
LEADERSHIP:
CEO: Colin Denver
CSO: Alison Todd
CFO: Jennifer Maher
FOLLOW SPEEDX:
Tweets by SpeeDx
31 articles about SpeeDx Pty. Ltd.
-
SpeeDx Close Series A Fundraising with Support from U.S. Venture Firm
4/23/2019
Northpond Ventures’ funds will support commercial menu expansion and completion of FDA clinical trials
-
SpeeDx and Cepheid Announce Test Partnership
4/16/2019
SpeeDx tests will be available through Cepheid’s FleXible Cartridge programme for the GeneXpert System
-
SpeeDx Distribution Network Expands to the Middle East
3/18/2019
Al Zahrawi Medical Supplies new distributor for Gulf Cooperation Council
-
SpeeDx Develops Multiplex Test for Respiratory Viruses
2/12/2019
New molecular assay, PlexPCR RespiVirus, submitted to TGA for clinical approval
-
Clinical data demonstrates significantly increased cure rates using Resistance Guided Therapy for treating the STI Superbug M. genitaliumSpeeDx ResistancePlus® MG test supports new STI management guidelines
6/21/2018
SpeeDx Pty. Ltd. announced clinical data contained in a new study published in the June 2018 issue of Clinical Infectious Diseases
-
SpeeDx And Diagen Sign New Distribution Agreement For Scandinavia
9/19/2017
-
SpeeDx Eyes Clear Path Toward Marketing Antibiotic Resistance And Detection Tests In US Market
7/24/2017
-
SpeeDx And Cepheid Announce European Distribution Partnership
6/8/2017
-
SpeeDx And Thermo Fisher Scientific Announce Strategic Partnership For FDA Clearance Of Molecular Diagnostic
4/25/2017
-
SpeeDx Release: Company And UgenTec Launch FastFinder For ResistancePlus MG Test
1/16/2017
-
SpeeDx Release: Evaluation Of Company's CE-Marked ResistancePlus MG Test For M. Genitalium Published In Journal Of Clinical Microbiology
1/11/2017